The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
SPDR S&P 500 ETF TR TR UNIT 78462F103   653,253,443 980,596 SH   SOLE   980,596 0 0
SURROZEN INC COM 86889P208   617,579 47,930 SH   SOLE   47,930 0 0
SURROZEN INC *W EXP 08/01/2 86889P117   517 33,333 SH   SOLE   33,333 0 0
TENAYA THERAPEUTICS INC COM 87990A106   472,761 291,828 SH   SOLE   291,828 0 0
VOR BIOPHARMA INC COM 929033207   223,868 4,595 SH   SOLE   4,595 0 0
XILIO THERAPEUTICS INC COM 98422T100   210,442 249,635 SH   SOLE   249,635 0 0
Q32 BIO INC COM 746964105   265,128 133,903 SH   SOLE   133,903 0 0
RAPT THERAPEUTICS INC COM 75382E208   236,546 9,172 SH   SOLE   9,172 0 0